The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: A systematic review protocol

BMJ Open

Volumn 4, Issue 2, 2014, Pages

  Kagina, Benjamin M ^a   Wiysonge, Charles S ^a,b   Machingaidze, Shingai ^a   Abdullahi, Leila H ^a   Adebayo, Esther ^a   Uthman, Olalekan A ^b,c   Hussey, Gregory D ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW INCOME COUNTRY; MALARIA; META ANALYSIS; MIDDLE INCOME COUNTRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY ANALYSIS; SOCIAL STATUS; SOCIOECONOMICS; SYSTEMATIC REVIEW; TUBERCULOSIS; VACCINATION; DEVELOPING COUNTRY; LITERATURE; METHODOLOGY; PATIENT ATTITUDE; PREVENTIVE HEALTH SERVICE; PROCEDURES; UTILIZATION;

DEVELOPING COUNTRIES; HUMANS; IMMUNIZATION PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC;

EID: 84896899780     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004429     Document Type: Article

References (37)

1. WHO. World TB Day, 24 March 2013. http://www.who.int/campaigns/tb-day/ 2013/event/en/ (accessed 1 Oct 2013).
2. Abu-Raddad LJ, Sabatelli L, Achterberg JT, et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci USA 2009;106:13980-5.
3. Brennan MJ, Stone MR, Evans T. A rational vaccine pipeline for tuberculosis. Int J Tuberc Lung Dis 2012;16:1566-73.
4. Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010;375:2110-19.
5. Machingaidze S, Wiysonge CS, Hussey GD. Strengthening the expanded programme on immunization in Africa: looking beyond 2015. PLoS Med 2013;10:e1001405.
6. Tao W, Petzold M, Forsberg BC. Routine vaccination coverage in low- and middle-income countries: further arguments for accelerating support to child vaccination services. Global Health Action 2013;6:20343.
7. WHO: Global Tuberculosis Report. 2012.
8. Weiss WM, Rahman MD, Solomon R, et al. Determinants of performance of supplemental immunization activities for polio eradication in Uttar Pradesh, India: social mobilization activities of the Social mobilization Network (SM Net) and Core Group Polio Project (CGPP). BMC Infect Dis 2013;13:17.
9. Yang J, Acosta CJ, Si GA, et al. A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial. BMC Public Health 2005;5:49.
10. Vijayaraghavan M, Martin RM, Sangrujee N, et al. Measles supplemental immunization activities improve measles vaccine coverage and equity: evidence from Kenya, 2002. Health Policy 2007;83:27-36. (Pubitemid 47058647)
11. Otten M, Kezaala R, Fall A, et al. Public-health impact of accelerated measles control in the WHO African Region 2000-03. Lancet 2005;366:832-9. (Pubitemid 41557383)
12. Wiysonge CS, Nomo E, Mawo JN, et al. Accelerated measles control in sub-Saharan Africa. Lancet 2006;367:394 -5.
13. Sutter RW, Maher C. Mass vaccination campaigns for polio eradication: an essential strategy for success. Curr Top Micro 2006;304:195-220. (Pubitemid 47413297)
14. Brotherton JM, Fridman M, May CL, et al. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011;377:2085-92.
15. Schaetti C, Ali SM, Chaignat CL, et al. Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar. PLoS ONE 2012;7:e41527.
16. Dietz V, Cutts F. The use of mass campaigns in the expanded program on immunization: a review of reported advantages and disadvantages. Int J Health Serv 1997;27:767-90. (Pubitemid 27516430)
17. Mahomed H, Ehrlich R, Hawkridge T, et al. TB incidence in an adolescent cohort in South Africa. PLoS ONE 2013;8:e59652.
18. Middelkoop K, Bekker LG, Liang H, et al. Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study. BMC Infect Dis 2011;11:156.
19. Hales S, de Wet N, Maindonald J, et al. Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet 2002;360:830-4. (Pubitemid 35257946)
20. Gushulak BD, MacPherson DW. Globalization of infectious diseases: the impact of migration. Clin Infect Di 2004;38:1742-8. (Pubitemid 38781667)
21. Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998;351:356-61. (Pubitemid 28052710)
22. Pawinski R, Debrus S, Delem A, et al. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa. J Infect Dis 2010;202(Suppl):S80-6.
23. Burchett HE, Mounier-Jack S, Griffiths UK, et al. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. Health Policy Plann 2012;27(Suppl 2):ii5-16.
24. Verguet S, Jassat W, Hedberg C, et al. Measles control in Sub-Saharan Africa: South Africa as a case study. Vaccine 2012;30:1594-600.
25. Verguet S, Jassat W, Bertram MY, et al. Impact of supplemental immunisation activity (SIA) campaigns on health systems: findings from South Africa. J Epidemiol Community Health 2013;67:947-52.
26. De Wals P, De Serres G, Niyonsenga T. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec. JAMA 2001;285:177-81. (Pubitemid 32048519)
27. Wiysonge CS, Mawo JN, Ticha JM, et al. Migration and measles. Int J Epidemiol 2005;34:1443-4.
28. Uzicanin A, Zhou F, Eggers R, et al. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa. Vaccine 2004;22:3419-26. (Pubitemid 39078760)
29. Zuber PL, Conombo KS, Traore AD, et al. Mass measles vaccination in urban Burkina Faso, 1998. B World Health Organ 2001;79:296-300. (Pubitemid 32303723)
30. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Oxford, UK, 2011.
31. Methodology Checklists; Health Improvement Scotland. http://www.sign.ac. uk/methodology/checklists.html.
32. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539- 58.
33. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
34. Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Oxford, UK, 2011.
35. Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992;48:577-85.
36. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001;54:1046-55. (Pubitemid 32888370)
37. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.